Advanced Medical Isotope ROE 2013-2025 | RDGL
Current and historical return on equity (ROE) values for Advanced Medical Isotope (RDGL) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Advanced Medical Isotope ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-09-30 | $0.00B | $0.00B | -160.00% |
| 2025-06-30 | $0.00B | $0.00B | -177.78% |
| 2025-03-31 | $0.00B | $0.00B | -200.00% |
| 2024-12-31 | $0.00B | $0.00B | -266.67% |
| 2024-09-30 | $0.00B | $0.00B | -320.00% |
| 2024-06-30 | $0.00B | $0.00B | -320.00% |
| 2024-03-31 | $0.00B | $0.00B | -320.00% |
| 2023-12-31 | $0.00B | $0.00B | -240.00% |
| 2023-09-30 | $0.00B | $0.00B | -200.00% |
| 2023-06-30 | $0.00B | $0.00B | -114.29% |
| 2023-03-31 | $0.00B | $0.00B | -133.33% |
| 2022-12-31 | $0.00B | $0.00B | -200.00% |
| 2022-09-30 | $0.00B | $0.00B | -160.00% |
| 2022-06-30 | $0.00B | $0.00B | -200.00% |
| 2022-03-31 | $0.00B | $0.00B | -240.00% |
| 2021-12-31 | $0.00B | $0.00B | -133.33% |
| 2021-09-30 | $0.00B | $0.00B | -160.00% |
| 2021-06-30 | $0.00B | $0.00B | -266.67% |
| 2021-03-31 | $0.00B | $0.00B | 0.00% |
| 2020-12-31 | $0.00B | $0.00B | 0.00% |
| 2020-09-30 | $0.00B | $0.00B | 100.00% |
| 2020-06-30 | $0.00B | $0.00B | 200.00% |
| 2020-03-31 | $0.00B | $0.00B | 200.00% |
| 2019-12-31 | $0.00B | $0.00B | 200.00% |
| 2019-09-30 | $0.03B | $0.00B | -2500.00% |
| 2019-06-30 | $0.00B | $0.00B | 10.53% |
| 2019-03-31 | $-0.01B | $0.00B | 58.33% |
| 2018-12-31 | $-0.01B | $0.00B | 61.54% |
| 2018-09-30 | $-0.04B | $-0.04B | 269.09% |
| 2018-06-30 | $-0.01B | $-0.01B | 200.00% |
| 2018-03-31 | $-0.01B | $-0.01B | 200.00% |
| 2017-12-31 | $-0.01B | $0.00B | 200.00% |
| 2017-09-30 | $0.00B | $0.00B | 123.08% |
| 2017-06-30 | $0.00B | $0.00B | 61.54% |
| 2017-03-31 | $0.00B | $0.00B | 106.67% |
| 2016-12-31 | $-0.01B | $0.00B | 153.85% |
| 2016-09-30 | $-0.01B | $0.00B | 109.09% |
| 2016-06-30 | $-0.01B | $-0.01B | 126.32% |
| 2016-03-31 | $0.00B | $-0.01B | 8.16% |
| 2015-12-31 | $0.01B | $-0.01B | -50.00% |
| 2015-09-30 | $-0.01B | $-0.01B | 54.55% |
| 2015-06-30 | $-0.01B | $-0.02B | 42.42% |
| 2015-03-31 | $-0.02B | $-0.02B | 100.00% |
| 2014-12-31 | $-0.02B | $-0.02B | 150.00% |
| 2014-09-30 | $0.00B | $-0.01B | 43.24% |
| 2014-06-30 | $0.00B | $-0.01B | 44.44% |
| 2014-03-31 | $0.00B | $-0.01B | 47.06% |
| 2013-12-31 | $0.00B | $-0.01B | 48.48% |
| 2013-09-30 | $-0.01B | $-0.01B | 82.35% |
| 2013-06-30 | $-0.01B | $-0.01B | 123.08% |
| 2013-03-31 | $-0.01B | $-0.01B | 177.78% |
| 2012-12-31 | $-0.01B | $-0.01B | 320.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Finance | Finance - SBIC & Commercial | $0.035B | $0.000B |
| Vivos Inc. is a late stage development company. It engaged primarily in the development of brachytherapy devices for therapeutic applications. Vivos Inc., formerly known as Advanced Medical Isotope Corporation, is based in Richland, Washington. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ares Capital (ARCC) | United States | $13.908B | 9.69 |
| Blue Owl Technology Finance (OTF) | United States | $5.933B | 8.44 |
| Blackstone Secured Lending Fund (BXSL) | United States | $5.693B | 7.55 |
| Main Street Capital (MAIN) | United States | $5.325B | 14.90 |
| Golub Capital BDC (GBDC) | United States | $3.325B | 8.15 |
| Hercules Capital (HTGC) | United States | $2.862B | 8.11 |
| Sixth Street Specialty Lending (TSLX) | United States | $1.821B | 8.78 |
| Morgan Stanley Direct Lending Fund (MSDL) | United States | $1.371B | 7.55 |
| Amalgamated Financial (AMAL) | United States | $1.239B | 11.31 |
| Trinity Capital (TRIN) | United States | $1.166B | 7.23 |
| Goldman Sachs BDC (GSBD) | United States | $1.053B | 5.56 |
| BARINGS BDC, INC (BBDC) | United States | $0.956B | 8.04 |
| Kayne Anderson BDC (KBDC) | United States | $0.955B | 8.17 |
| Bain Capital Specialty Finance (BCSF) | United States | $0.880B | 6.99 |
| New Mountain Finance (NMFC) | United States | $0.858B | 6.50 |
| Nuveen Churchill Direct Lending (NCDL) | United States | $0.694B | 7.10 |
| Fidus Investment (FDUS) | United States | $0.687B | 8.77 |
| Carlyle Secured Lending (CGBD) | United States | $0.607B | 7.22 |
| Gladstone Investment (GAIN) | United States | $0.557B | 14.72 |
| Crescent Capital BDC (CCAP) | United States | $0.517B | 7.28 |
| CION Investment (CION) | United States | $0.450B | 4.88 |
| Gladstone Capital (GLAD) | United States | $0.419B | 9.18 |
| BLACKROCK TCP CAPITAL CORP (TCPC) | United States | $0.407B | 3.48 |
| Saratoga Investment Corp (SAR) | United States | $0.373B | 9.56 |
| Palmer Square Capital BDC (PSBD) | United States | $0.357B | 6.60 |
| PennantPark Investment (PNNT) | United States | $0.337B | 8.32 |
| Stellus Capital Investment (SCM) | United States | $0.332B | 8.02 |
| Runway Growth Finance (RWAY) | United States | $0.310B | 5.30 |
| Horizon Technology Finance (HRZN) | United States | $0.309B | 5.90 |
| Medallion Financial (MFIN) | United States | $0.239B | 5.55 |
| Chicago Atlantic BDC (LIEN) | United States | $0.234B | 13.31 |
| TriplePoint Venture Growth BDC (TPVG) | United States | $0.228B | 5.00 |
| WhiteHorse Finance (WHF) | United States | $0.152B | 5.60 |
| Oxford Square Capital (OXSQ) | United States | $0.148B | 5.48 |
| PhenixFIN (PFX) | United States | $0.085B | 15.17 |
| Investcorp Credit Management BDC (ICMB) | United States | $0.044B | 18.12 |
| Rand Capital (RAND) | United States | $0.033B | 7.32 |
| OFS Capital (OFS) | United States | $0.000B | 4.03 |
| SLR Investment (SLRC) | United States | $0.000B | 9.09 |
| FS KKR Capital (FSK) | United States | $0.000B | 10.41 |